Another Pd(II) complex 42 with a terpyridine ligand and saccharinate counterion was investigated in vivo in an Ehrlich Ascites Carcinoma solid tumor model in comparison with cisplatin and paclitaxel, and their effects on p53 and other markers were assessed in tumor tissues using immunohistochemistry [152]. This evidence concerns the gene TP53 and neoplasm.